• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA28-70/I20-30
Device Problem Separation Problem (4043)
Patient Problems Abdominal Pain (1685); Ruptured Aneurysm (4436)
Event Date 12/02/2023
Event Type  Injury  
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, endologix practices making at least three good-faith efforts to retrieve a reported adverse event/incident-related device, as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows that the device was properly manufactured and released in accordance with the device master record.The review confirms that there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows that type iiia endoleak, rupture, and additional endovascular procedure complaints are unconfirmed.This is not consistent with the reported adverse event/incident.The procedure-related harms, device, user, procedure, or anatomy-relatedness of this complaint could not be determined with the medical records available for review.The final patient status was reported to be in stable condition.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.
 
Event Description
The patient underwent treatment for an abdominal aortic aneurysm (aaa) with the implantation of an afx2 bifurcated stent graft, afx vela suprarenal, and a gore (non-endologix) excluder.This initial procedure falls outside the indications for use (off-label) due to the utilization of adjunctive devices that are not compatible with the afx system.Approximately three and a half (3.5) years post the initial procedure, the patient reported experiencing chest and stomach pain since the end of november 2023.The patient lost consciousness and was transferred to another hospital on (b)(6), 2023.A computed tomography (ct) scan revealed implant separation, an endoleak type iiia and intra-abdominal bleeding, resulting in the diagnosis of a rupture (aorta).The patient was then transferred to another hospital, where an emergency re-intervention took place.During this procedure, a gore (non-endologix) ctag was implanted under the renal artery, and two (2) gore (non-endologix) excluder cuffs were added.It was reported that the re-intervention effectively resolved the endoleak type iiia.The final patient status was reported as stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
,
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
,
irvine, CA 92618
8009832284
MDR Report Key18465790
MDR Text Key332326166
Report Number3011063223-2024-00002
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014566
UDI-Public(01)00818009014566(17)230214
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Distributor
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial
Report Date 12/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/14/2023
Device Model NumberBEA28-70/I20-30
Device Lot Number2332682-003
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/07/2023
Initial Date FDA Received01/08/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-0007-2019
Patient Sequence Number1
Treatment
AFX VELA SUPRARENAL (B)(6).; GORE (NON-ENDOLOGIX) EXCLUDER (B)(6).
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-